Mary Learner spent her graduate school career studying Shakespeare and other Renaissance writers while Brianna Vickerman was in a chemistry lab studying the delivery of therapeutic drugs. In the course of obtaining doctorates in English and comparative literature and chemistry, the two haven’t typically crossed paths. However, both women, along with students who are getting advanced degrees in fields like journalism, public health and government, are participating in The Graduate School at UNC-Chapel Hill’s new program CareerWell this spring.
Students across the country have felt anxious while trying to launch their careers in a depressed job market. Despite having excellent academic mentors, many haven’t known where to turn for help as they look for jobs outside of academia. Leaders in The Graduate School observed changes in the job market and were considering options for additional career training services. Then, the 2020 economic downturn and a struggling job market, that�
An orange-red dye shows that blood clots formed in a mouse ear in which thrombin was released from light-triggered RBCs. Scale bar, 50 μm. Credit: Adapted from ACS Central Science 2020, DOI: 10.1021/acscentsci.0c01151 Read Time:
Protein therapies are often more potent and selective toward their biochemical targets than other types of drugs, particularly small molecules. However, proteins are also more likely to be quickly degraded by enzymes or cleared from blood by the kidneys, which has limited their clinical use. Now, researchers reporting in
ACS Central Science have engineered red blood cell (RBC) carriers that release therapeutic proteins when stimulated by light, with the help of a honey bee peptide.